From Arkuda Unveils $44M and a Protein Restoration Approach to Dementia:

Gerhard-Koenig
Gerhard-Koenig

Gerhard Koenig, co-founder, president, and CEO of Arkuda Therapeutics. Photo by Arkuda Therapeutics